Our hypothesis is that MRI relaxation time can monitor breast cancer cell growth by measuring the influence of Her-2 expression and intracellular matrix development on proton mobility in MCF-7 Her-2 positive cells. This evidence concerns the gene ERBB2 and breast carcinoma.